medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2006, Number 2

<< Back Next >>

Ann Hepatol 2006; 5 (2)

Post-liver transplantation medical complications

Moreno R, Berenguer M

Language: English
References: 42
Page: 77-85
PDF size: 104.88 Kb.


Text Extraction

Liver transplantation (LT) is widely accepted as an effective therapeutic modality for a variety of irreversible acute and chronic liver disease. The success of liver transplantation has increased steadily over the last two decades and several advances have been made since the first human liver transplant. This procedure has become routine with an excellent outcome in terms of both quality and length of survival. The results of liver transplantation have improved due to advances in perioperative technique, a better understanding of the course and prognosis of several liver disease, improved immunosuppressive therapy and more effective postoperative care. Nevertheless, improved tools detecting under immunosuppression, new strategies against viral infections (i.e. cytomegalovirus), and new immunosuppressive drugs will probably even prevent further graft dysfunction in the future. However, complications are common in the early and long term period and contribute to significant morbidity and mortality. One of the major challenges facing the transplant community is the increasing metabolic complications that are now affecting quality of life and long-term survival. Thus, knowledge of complications that emerge during follow up period, early and accurate establishment of diagnosis, and prompt institution of appropriate interventions are essential for optimal patient and graft outcome.
This review summarizes available data about medical complications of the early and long term follow up.


REFERENCES

  1. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a diseasespecific analysis of the UNOS database. Liver Transpl 2004; 10: 886-897.

  2. Lucey MR, Brown KA, Everson GT. Minimal criteria for placement of adults on the liver transplant waiting list: A report of national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Disease. Liver Transplant Surg 1997; 3: 628-637.

  3. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transpl Surg 1997; 3: 93-104.

  4. Devlin J, O’Grady J. Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut 1999; 45 Suppl 6: VI1-VI22.

  5. Hepp J, Innocenti FA. Liver transplantation in Latin America: current status. Transplant Proc 2004; 36: 1667-8.

  6. Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001; 120: 749-762.

  7. Murray KF, Carithers RL Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407-32.

  8. Munoz SJ, Rothstein KD, Reich D, Manzarbeitia C. Long-term care of the liver transplant recipient. Clin Liver Dis 2000; 4: 691-710.

  9. Wiesner R, Rakela J, Ishitani M, Mulligan D, Spivey J, Steers J, et al. Recent advances in liver transplantation. Mayo Clinic Proceedings 2003; 78: 197-210.

  10. Mazariegos GV, Molmenti EP, Kramer DJ. Early complications after orthotopic liver transplantation. Surg Clin North Am 1999; 79: 109-29.

  11. Pastacaldi S, Teixeira R, Montalto P, Rolles K, Burroughs AK. Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl 2001; 7: 75-81.

  12. Vivarelli M, Cucchetti A, La Barba G, Bellusci R, De Vivo A, Nardo B, Cavallari A, Pinna AD. Ischemic arterial complications after liver transplantation in the adult: multivariate analysis of risk factors. Arch Surg 2004; 139: 1069-74.

  13. Moser MA, Wall WJ. Management of biliary problems after liver transplantation. Liver Transpl 2001; 7(Suppl 1): S46-52.

  14. Motschman TL, Taswell HF, Brecher ME, Rakela J, Grambsch PM, Larson-Keller J, et al. Intraoperative blood loss and patient and graft survival in orthotopic liver transplantation: their relationship to clinical and laboratory data. Mayo Clin Proc 1989; 64: 346-55.

  15. De Boer MT, Molenaar IQ, Hendriks HG, Slooff MJ, Porte RJ. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg 2005; 22: 265-75.

  16. Snowden CP, Hughes T, Rose J, Roberts DR. Pulmonary edema in patients after liver transplantation. Liver Transpl 2000; 6: 466-70.

  17. Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998; 12: 123-129.

  18. Lewis M, Howdle P. Neurologic complications of liver transplantation in adults. Neurology 2003; 61: 1174-1178.

  19. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998; 15(66): 302-10.

  20. Demetris AJ. Central venulitis in liver allografts: considerations of differential diagnosis. Hepatology 2001; 33: 1329-30.

  21. Lovell MO, Speeg KV, Halff GA, Molina DK, Sharkey FE. Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode. Liver Transpl 2004; 10: 369-73.

  22. Varotti G, Grazi GL, Vetrone G, Ercolani G, Cescon M, Del Gaudio M, Ravaioli M, et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant 2005; 19: 492-500.

  23. Gayowski T, Marino IR, Singh N, Doyle H, Wagener M, Fung JJ, Starzl TE. Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation 1998; 65: 499-504.

  24. Singh N. The current management of infectious diseases in the liver transplant recipient. Clin Liver Dis 2000; 4: 657-73.

  25. Losada I, Cuervas-Mons V, Millan I, Damaso D. Early infection in liver transplant recipients: incidence, severity, risk factors and antibiotic sensitivity of bacterial isolates. Enferm Infecc Microbiol Clin 2002; 20: 422-30.

  26. Arnow PA. Antibiotic prophylaxis: the role of selective bowel decontamination. Curr Opin Organ Transplant 2001; 6: 301-4.

  27. Paterson DL, Rihs JD, Squier C, Gayowski T, Sagnimeni A, Singh N. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation 2003; 75: 194-8.

  28. Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Muller AR, Steinmuller T, Neuhaus P. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl 2002; 8: 1138-46.

  29. Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection? Transpl 2005; 11: 700-704.

  30. Reuben A. Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl 2001; 7(Suppl 1): S13-21.

  31. Backman L, Gibbs J, Levy M, McMillan R, Holman M, Husberg B, Goldstein, et al. Causes of late graft loss after liver transplantation. Transplantation 1993; 55: 1078-82.

  32. Demetris AJ. Spectrum of chronic hepatic allograft rejection and arteriopathy and the controversy of centrilobular necrosis. Liver Transpl 2000; 6: 102-3.

  33. Gonwa TA. Hypertension and renal dysfunction in long-term liver transplant recipients. Liver Transpl 2001; 7(Suppl 1): S22-6.

  34. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001; 72: 1934-9.

  35. Rimola A, Londono MC, Guevara G, Bruguera M, Navasa M, Forns X, Garcia-Retortillo M, et al. Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation. Transplantation 2004; 78: 686-91.

  36. Rabkin JM, Corless CL, Rosen HR, Olyaei AJ. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. Am J Surg 2002; 183: 595-9.

  37. Navasa M, Bustamante J, Marroni C, Gonzalez E, Andreu H, Esmatjes E, Garcia-Valdecasas JC, Grande L, Cirera I, Rimola A,Rodes J. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25(1): 64-71.

  38. Correia MITD, Rego LO, Lima AS. Post-liver transplant obesity and diabetes. Curr Opin Clin Nutr Metab Care 2003; 4: 457-60.

  39. Bjoro K, Brandsaeter B, Wiencke K, Bjoro T, Godang K, Bollerslev J, Schrumpf E. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease. Scand J Gastroenterol 2003; 38: 320-7.

  40. Hay JE, Guichelaar MM. Evaluation and management of osteoporosis in liver disease. Clin Liver Dis 2005; 9: 747-66.

  41. Berenguer M, Prieto M, Bustamante M, Carrasco D, Lopez-Andujar R, Mir J, Berenguer J. Incidence of de novo neoplasms after liver transplantation. Med Clin Barc 1998; 111: 481-4.

  42. Benlloch S, Berenguer M, Prieto M, Moreno R, et al. De novo internal neoplasms after liver transplantation: increased risk and aggressive behavior in recent years? Am J Transplant 2004; 4(4): 596-604.




2020     |     www.medigraphic.com